Al (@allie_aa_) 's Twitter Profile Photo

🚨🚨RNS Big win for #AVCT today. Today’s RNS isn’t just about £3.25M and a bond deferral alone, but also about Optics. The financing overhang is gone, the balance sheet stabilised, and the clinical runway now extended to 2027. That flips risk averse Pharma giants’ view of #AVCT

Daringinsights (@royaldaring) 's Twitter Profile Photo

#avct is now further derisked and looks more promising by the day. A matter of sitting tight and hold on to those amazing shares. Day to day movements are for the daytraders.

Ben (@111ben_111) 's Twitter Profile Photo

#AVCT crawled through half a mile of sewage the past few years, like Andy Dufresne, and has finally emerged into the light. Free of the death spiral. A deal is coming,and from the sounds of it, not just upfront cash, but a pharma co taking a stake in Avacta

#AVCT crawled through half a mile of sewage the past few years, like Andy Dufresne, and has finally emerged into the light. 

Free of the death spiral. 

A deal is coming,and from the sounds of it, not just upfront cash, but a pharma co taking a stake in Avacta
RAH (@rah00084) 's Twitter Profile Photo

The #AVCT value funnel is tantalising: ✍️ pre|CISION to another warhead 🇩🇪 Tap @ #ESMO25 🩻 SGC data ☢️ AVA6000 long term safety data 🩻 TNBC data 🪑#Hughes4Chair ✍️ AVA6000 (multiple indications) 📑 AVA6103 IND filed 🧬 AVA6103 enters human 🤝 Acquired

LivingInTheSurf (@livinginthesurf) 's Twitter Profile Photo

#AVCT I know a share cannot just rebound instantly but this share should never be down here. It’s an absolute gem 💎 with complete dominance potential of solid tumors. Proven and close to a major drug rolling into revenue. How is it so cheap. Takeover 5 to 10bil is too cheap now

Wolfiesmith18 (@wolfiesmith18) 's Twitter Profile Photo

🔥 Today’s RNS = game changer 🔥 ✅ RH delivers AGAIN + kept AGM promises ✅ CLN finally sorted after 3yrs 🚀 ✅ Deadwood in comms gone ✅ Science powering forward – bigger catalysts coming ✅ Change = strength Massive credit to CC & RH 👏 #Hughes4Chair #AVCT

Gall bag Surgeon (@gallbagsurgeon) 's Twitter Profile Photo

#avct Daily chart. Possible inverse head and shoulders completing with measured move target in 90s. (Needs a close above 60 to confirm). Impending "golden cross" of rising 50 day MA (purple) over 200 day MA (red).

#avct Daily chart. Possible inverse head and shoulders completing with measured move target in 90s. (Needs a close above 60 to confirm). Impending "golden cross" of rising 50 day MA (purple) over 200 day MA (red).
Share_Talk ™ (@share_talk) 's Twitter Profile Photo

Trader's Café #BulletinBoardHeroes, Friday 29th August 2025 #FTSE100 #DAX #DOW #BTC #ETH #GOLD #APTA #AVCT #AET #AOM #CGNR #DIA #GWMO #GCM #HEMO #IMM #MAST #RCFX Zaks Traders Cafe

Share_Talk ™ (@share_talk) 's Twitter Profile Photo

Market Summary > Avacta LON #AVCT 62.75 GBX+7.75 (14.09%)⤴️ 29 Aug, 11:47 BST • Disclaimer Near-term resistance is around 64p. A rising 200-day (and an approaching golden cross) would strengthen the bull case; the next bigger resistance cluster is in the 80–85p area.

MB (@mbinvest) 's Twitter Profile Photo

Well would you look at that - I’m sat in profit on speculative holding Avacta #avct. What a slog. Golden cross incoming today also.

asininityandbeyond (@asininitybeyond) 's Twitter Profile Photo

Items 1 + 2 tying-up mentions of Radio Tx + inhibitors by CC in last 9 months, plus nod to $LLY progressing CanSeek tech per PL note Suspect item 2 would be “Product F” of which #AVCT sees double digit royalty - using proprietary BP warhead, likely pathway inhibitor All IMO!